Frameworks for approaching prescribing at the end of life [1]

Archives of Internal Medicine

Volumn 166, Issue 21, 2006, Pages 2404-

  Currow, David C ^a   Abernethy, Amy P ^b  

^a Southern Adelaide Palliative Services   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

HEART INFARCTION; HUMAN; LETTER; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 33751509966     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.21.2404-a     Document Type: Letter

References (6)

1. Holmes HM, Cox-Hayley D, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605-609.
2. Stevenson J, Miller C, Abernethy AP, Currow DC. Management of long-term comorbidities in the setting of end stage disease. BMJ. 2004;329:909-912.
3. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289:2387-2392.
4. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452-454.
5. Smeeth L, Haines A, Ebrahim S. Numbers needed to treat derived from meta-analyses - sometimes informative, usually misleading. BMJ. 1999;318:1548-1551.
6. Fink DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724.